Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00997035 · ClinicalTrials.gov registry record · Phase 3
The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo
A Phase 3 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 3
- Development phase
- 240
- Enrollment target
NCT00997035 is a Phase 3 study that has completed, run by University of California, San Francisco. The registered enrollment target is 240 participants.
The verdict
NCT00997035, a Phase 3 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 240 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the addition of oral voriconazole to topical treatment regimens results in lower rates of perforation in severe fungal corneal ulcers.
Interventions
- DRUG Placebo
- DRUG Voriconazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2010-05 |
| Est. Completion | 2016-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00997035
The ClinicalTrials.gov registry entry for NCT00997035 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00997035 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00997035 about?
NCT00997035 is a clinical study titled "The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo". The purpose of this study is to determine if the addition of oral voriconazole to topical treatment regimens results in lower rates of perforation in severe fungal corneal ulcers.
What is the current status of trial NCT00997035?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 240 participants. The study started on 2010-05. Estimated completion is 2016-03.
What interventions are being tested in trial NCT00997035?
The interventions under investigation include: Placebo (DRUG), Voriconazole (DRUG).
Who is sponsoring clinical trial NCT00997035?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.